Automating economic analysis of co-medication use in clinical trials

被引：0
|
作者：
Waldeck, R
Kawabata, H
Yuan, Y
机构：
[1] Bristol Myers Squibb, Wallingford, CT USA
[2] Bristol Myers Squibb, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)63807-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：180 / 180
页数：1
相关论文
共 50 条
  • [41] Co-medication and potential drug interactions among patients with epilepsy
    Bosak, Magdalena
    Slowik, Agnieszka
    Iwanska, Anna
    Lipinska, Milena
    Turaj, Wojciech
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2019, 66 : 47 - 52
  • [42] Co-medication management: key to optimize the efficacy and tolerability of Cenobamate
    Sanchez-Caro, J.
    Hariramani-Ramchandani, R.
    Maestro-Saiz, I.
    Abril-Jaramillo, J.
    Monge-Marquez, E.
    Perez-Diaz, H.
    Alonso-Vanegas, M.
    Rodriguez-Uranga, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 116 - 116
  • [43] A Partitioning-based Approach for Clustering COVID-19 Drugs and Co-Medication for Safe Use
    Alqurneh, Ahmad
    Mustapha, Aida
    Sharef, Nurfadhlina Mohd
    INTERNATIONAL JOURNAL OF INTEGRATED ENGINEERING, 2020, 12 (05): : 224 - 232
  • [44] Integrating economic analysis into clinical trials
    Imai, K
    Zhang, P
    LANCET, 2005, 365 (9473): : 1749 - 1750
  • [45] Protracted Episode of Reduced Consciousness Following Co-Medication with Omeprazole and Clorazepate
    Achim Konrad
    Clinical Drug Investigation, 2000, 19 : 307 - 311
  • [46] Increase in plasma concentrations of amisulpricle after receiving co-medication with lithium
    Bergemann, N
    Kress, KR
    Abu-Tair, F
    Frick, A
    Kopitz, J
    PHARMACOPSYCHIATRY, 2005, 38 (01) : 44 - 44
  • [47] The Role of Conventional DMARDs Co-medication in TNF Inhibitor Drug Survival
    Kwan, Andrew
    Chow, Jocelyn
    Shah, Alpesh
    Soucy, Elaine
    Chow, Andrew
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 908 - 909
  • [48] Serum concentrations of levetiracetam in epileptic patients:: The influence of dose and co-medication
    May, TW
    Rambeck, B
    Jürgens, U
    THERAPEUTIC DRUG MONITORING, 2003, 25 (06) : 690 - 699
  • [49] Co-medication and polypharmacy with ADHD medications in adults: a Swedish nationwide study
    Zhang, L.
    Reif, A.
    Du Rietz, E.
    Lagerberg, T.
    Butwicka, A.
    D'Onofrio, B. M.
    Johnell, K.
    Pedersen, N. L.
    Larsson, H.
    Chang, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S28 - S29
  • [50] Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin
    Haertter, Sebastian
    Koenen-Bergmann, Michael
    Sharma, Ashish
    Nehmiz, Gerhard
    Lemke, Ute
    Timmer, Wolfgang
    Reilly, Paul A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (03) : 490 - 500
12345